ADRENOCORTICAL CARCINOMA (ACC)
Clinical trials for ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA (ACC) trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancers: targeted chemo plus immune booster
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal, bile duct, or adrenal cancer will receive treatment through a pump place…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New radiation approach before surgery for rare adrenal cancer shows promise
Disease control Recruiting nowThis early-phase trial tests giving radiation therapy before surgery for people whose adrenal cancer has come back. The goal is to find the safest radiation dose and see if it helps shrink tumors before removal. About 32 adults with recurrent but operable adrenal cancer will rece…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC